DO PREDICTORS OF IV ABATACEPT RETENTION DEPEND ON THE LINE OF RHEUMATOID ARTHRITIS TREATMENT: 12-MONTH INTERIM ANALYSIS OF THE OBSERVATIONAL, PROSPECTIVE ACTION STUDY

被引：3
|
作者：
Alten, R. [1 ]
Nuesslein, H. [2 ]
Galeazzi, M. [3 ]
Lorenz, H. M. [4 ]
Mariette, X. [5 ]
Cantagrel, A. [6 ]
Chartier, M. [7 ]
Elbez, Y. [8 ]
Rauch, C. [9 ]
Le Bars, M. [10 ]
机构：
[1] Schlosspk Klin Univ Med, Berlin, Germany
[2] Univ Erlangen Nurnberg, Nurnberg, Germany
[3] Univ Siena, Siena, Italy
[4] Univ Hosp, Heidelberg, Germany
[5] Univ Paris Sud, Paris, France
[6] Hop Purpan, Toulouse, France
[7] Chiltern Int, Neuilly, France
[8] Excelya, Boulogne, France
[9] Bristol Myers Squibb, Munich, Germany
[10] Bristol Myers Squibb, Rueil Malmaison, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.1289
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0066
引用
收藏
页码：202 / 202
页数：1
相关论文
共 50 条
  • [1] Real-world Efficacy and Safety of Abatacept Treatment for Rheumatoid Arthritis: 12-Month Interim Analysis of the ACTION Study
    Bensen, William
    Nuesslein, Hubert
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Boumpas, Dimitrios
    Nurmohamed, Michael
    Burmester, Gerd
    Peter, Hans-Hartmut
    Rainer, Franz
    Pavelka, Karel
    Charner, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 985 - 985
  • [2] REAL-WORLD EFFICACY AND SAFETY OF ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS: 12-MONTH INTERIM ANALYSIS OF THE ACTION STUDY
    Nusslein, Hubert
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hannes M.
    Boumpas, Dimitrios
    Nurmohamed, Michael T.
    Bensen, William
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Rainer, Franz
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. RHEUMATOLOGY, 2013, 52 : 90 - 91
  • [3] Real-World Efficacy and Safety of Abatacept Treatment for Rheumatoid Arthritis: 12-Month Interim Analysis of the Action Study.
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H. M.
    Boumpas, Dimitrios
    Nurmohamed, M. T.
    Bensen, W.
    Burmester, G. R.
    Peter, H. -H.
    Rainer, F.
    Pavelka, Karel
    Chartier, M.
    Poncet, C.
    Rauch, C.
    Le Bars, M.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S199 - S200
  • [4] Body Mass Index does not Impact Abatacept Retention in BiologicNaive Patients with Rheumatoid Arthritis who have Poor Prognostic Factors: A 12-Month Interim Analysis of an Observational, Prospective Study
    Alten, Rieke
    Lorenz, Hannes
    Nuesslein, Hubert
    Mariette, Xavier
    Galeazzi, Mauro
    Cantagrel, Alain
    Chartier, Melanie
    Elbez, Yedid
    Rauch, Christiane
    Le Bars, Manuela
    Muratti, Eleonora
    [J]. JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 892 - 893
  • [5] Body Mass Index Does Not Impact Abatacept Retention in Biologic-Naive Patients with Rheumatoid Arthritis Who Have Poor Prognostic Factors: A 12-Month Interim Analysis of an Observational, Prospective Study
    Alten, R.
    Lorenz, H-M
    Nusslein, H. G.
    Mariette, X.
    Galeazzi, M.
    Cantagrel, A.
    Chartier, M.
    Elbez, Y.
    Rauch, C.
    Le Bars, M.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
    Nuesslein, Hubert G.
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Boumpas, Dimitrios
    Nurmohamed, Michael T.
    Bensen, William G.
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Rainer, Franz
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2014, 15
  • [7] Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
    Hubert G Nüßlein
    Rieke Alten
    Mauro Galeazzi
    Hanns-Martin Lorenz
    Dimitrios Boumpas
    Michael T Nurmohamed
    William G Bensen
    Gerd R Burmester
    Hans-Hartmut Peter
    Franz Rainer
    Karel Pavelka
    Melanie Chartier
    Coralie Poncet
    Christiane Rauch
    Manuela Le Bars
    [J]. BMC Musculoskeletal Disorders, 15
  • [8] BURDEN OF FIRST OSTEOPOROTIC HIP FRACTURE IN SPAIN: RESULTS OF THE INTERIM ANALYSIS OF A 12-MONTH, PROSPECTIVE, OBSERVATIONAL STUDY
    Caeiro
    Alvarez-Nebreda, L.
    Mesa, M.
    Sorio, F.
    Gatell, S.
    Ghelani, P.
    Farre, A.
    Feudjo, M.
    Canals, L.
    Arellano, J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S108 - S108
  • [9] Time to Discontinuation and Effectiveness with Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study
    Alten, Rieke
    Burmester, Gerd
    Matucci-Cerinic, Marco
    Ostor, Andrew
    Zaremba-Pechmann, Liliana
    Treuer, Tamas
    Ng, Khai Jing
    Gerwien, Jens
    Gibson, Kathryn
    Fautrel, Bruno
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2796 - 2798
  • [10] Time to Discontinuation and Effectiveness of Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study
    Alten, R.
    Burmester, G.
    Matucci-Cerinic, M.
    Ostor, A.
    Zaremba-Pechmann, L.
    Treuer, T.
    Ng, K.
    Gerwien, J.
    Gibson, K.
    Fautrel, B.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 : 60 - 61
12345